AXSOME THERAPEUTICS INC (AXSM:NASDAQ)
$238.77 0.4 (0.1678%)
Analysed AXSOME THERAPEUTICS INC (AXSM:NASDAQ) News Sources
Axsome Therapeutics (AXSM) Following FOCUS 2 Dosing Is The ADHD Upside Already Priced In
09-07-2026
yahoo.com
How Investors May Respond To Axsome Therapeutics (AXSM) Advancing Solriamfetol Into Phase 3 Pediatric ADHD Trials
09-07-2026
yahoo.com
Axsome Therapeutics (AXSM) Stock Looks Pricey On Sales Yet Fair On Value
10-07-2026
yahoo.com
3 Under-the-Radar Stocks to Buy and Hold
10-07-2026
fool.com
Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10
14-07-2026
yahoo.com
Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy
15-07-2026
yahoo.com
Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance
16-07-2026
yahoo.com
Jazz Pharmaceuticals (JAZZ) Refocuses Its Sleep Franchise, Is The Stock Still Cheap?
18-07-2026
yahoo.com
Shopify downgraded, Five Below upgraded: Wall Street's top analyst calls
21-07-2026
yahoo.com
Axsome Therapeutics (AXSM) Stock is Attractive on the Back of its Key Drug
24-07-2026
yahoo.com
What is the current price of AXSOME THERAPEUTICS INC (AXSM:NASDAQ)?
The current price of AXSOME THERAPEUTICS INC (AXSM:NASDAQ) is $238.77.
AXSOME THERAPEUTICS INC (AXSM:NASDAQ) absolute price change since previous trading day?
The absolute price change of AXSOME THERAPEUTICS INC (AXSM:NASDAQ) since the previous trading day is $0.4.
AXSOME THERAPEUTICS INC (AXSM:NASDAQ) percentage price change since previous trading day?
The percentage price change of AXSOME THERAPEUTICS INC (AXSM:NASDAQ) since the previous trading day is 0.1678%.
What is the most recent average sentiment score for AXSOME THERAPEUTICS INC (AXSM:NASDAQ)?
The most recent average sentiment score for AXSOME THERAPEUTICS INC (AXSM:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for AXSOME THERAPEUTICS INC (AXSM:NASDAQ)?
The most recent sentiment for AXSOME THERAPEUTICS INC (AXSM:NASDAQ) is .
SEC-8K** Filing Available For AXSOME THERAPEUTICS INC (AXSM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.